VOCxi and S3 partner to develop lung cancer detection and monitoring tech
The partnership will build on VOCxi Health’s BreathEZ device that aims to help lung cancer detection.
23 August 2023
23 August 2023
The partnership will build on VOCxi Health’s BreathEZ device that aims to help lung cancer detection.
The device has been used in 15 patients to provide temporary circulatory support during percutaneous coronary intervention procedures.
The device facilitates the visualisation of patient settings and data from outside the room.
The company has recorded revenues of $7.7bn for the quarter.
The multicentre, crossover study will enrol 16 subjects with HFpEF caused by hypertension.
According to the WHO, in 2017, Africa held more than 24% of the global burden of diseases.
More patent applications are presently pending in India, Korea, Japan, China, Singapore, New Zealand, Israel and Europe.
The dawn of generative artificial intelligence is expected to change how life sciences companies are organised.
Enter the Excellence Awards today! This program offers multiple benefits, such as gaining visibility among the market, your employees, and prospective clients for your achievement. To learn more about benefits, entry details, and available marketing packages, download the Research Guide.
GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.